We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+12.8%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.21B
AUM Growth
-$296M
Cap. Flow
-$592M
Cap. Flow %
-18.42%
Top 10 Hldgs %
43.24%
Holding
304
New
89
Increased
36
Reduced
82
Closed
88

Top Buys

Rank Stock Value
1
ATAI icon
AtaiBeckley Inc
ATAI
+$25.3M
2
AGL icon
Agilon Health
AGL
+$13.5M
3
LLY icon
Eli Lilly
LLY
+$13.2M
4
PRVA icon
Privia Health
PRVA
+$12.8M
5
LNTH icon
Lantheus
LNTH
+$12.3M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$23.9M
2
VCEL icon
Vericel Corp
VCEL
+$20.8M
3
ALGN icon
Align Technology
ALGN
+$19M
4
SIBN icon
SI-BONE Inc
SIBN
+$17.5M
5
STAA icon
STAAR Surgical
STAA
+$14.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.64%
2 Industrials 1.41%
3 Materials 0.54%
4 Financials 0.48%
5 Consumer Staples 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BFLY.WS
226
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
– –
-533,372
Closed -$3.44M
CDNA icon
227
PUT
CareDx
CDNA
$2.44B
– –
-70,000
Closed -$4.77M
CI icon
228
PUT
Cigna
CI
$73.1B
– –
-160,000
Closed -$38.7M
CNMD icon
229
CONMED
CNMD
$1.49B
– –
-65,000
Closed -$8.49M
COO icon
230
CALL
Cooper Companies
COO
$15B
– –
-182,000
Closed -$17.5M
COO icon
231
Cooper Companies
COO
$15B
– –
-86,584
Closed -$8.31M
CRIS icon
232
CALL
Curis
CRIS
$3.57M
– –
-1,493
Closed -$6.76M
CRL icon
233
PUT
Charles River Laboratories
CRL
$13.7B
– –
-30,000
Closed -$8.7M
CSTL icon
234
PUT
Castle Biosciences
CSTL
$968M
– –
-156,000
Closed -$10.7M
CYRX icon
235
PUT
CryoPort
CYRX
$748M
– –
-147,800
Closed -$7.69M
DRIO icon
236
DarioHealth
DRIO
$72.8M
– –
-18,735
Closed -$6.86M
DTIL icon
237
Precision BioSciences
DTIL
$205M
– –
-3,370
Closed -$1.05M
FOLD
238
DELISTED
Amicus Therapeutics
FOLD
– –
-45,525
Closed -$444K
FOLD
239
PUT
DELISTED
Amicus Therapeutics
FOLD
– –
-101,300
Closed -$1M
FULC icon
240
Fulcrum Therapeutics
FULC
$285M
– –
-126,068
Closed -$1.49M
FXH icon
241
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
– –
-402,000
Closed -$43.7M
GILD icon
242
Gilead Sciences
GILD
$168B
– –
-50,602
Closed -$3.27M
IART icon
243
PUT
Integra LifeSciences
IART
$1.34B
– –
-165,400
Closed -$11.4M
IBB icon
244
PUT
iShares Biotechnology ETF
IBB
$9.84B
– –
-350,000
Closed -$52.7M
IDYA icon
245
IDEAYA Biosciences
IDYA
$3.53B
– –
-60,744
Closed -$1.43M
INCY icon
246
Incyte
INCY
$24.5B
– –
-110,750
Closed -$9M
INNV icon
247
InnovAge Holding
INNV
$1.42B
– –
-251,225
Closed -$6.48M
INO icon
248
CALL
Inovio Pharmaceuticals
INO
$79.4M
– –
-16,667
Closed -$1.86M
INO icon
249
PUT
Inovio Pharmaceuticals
INO
$79.4M
– –
-2,692
Closed -$300K
IWM icon
250
PUT
iShares Russell 2000 ETF
IWM
$82.2B
– –
-1,392,500
Closed -$308M
8 9
10
11 12

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2021 Portfolio in Review

As of Q2 2021, Pura Vida Investments held 304 positions worth $3.21B, down 8.4% from $3.51B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pura Vida Investments withdrew a net $592M in Q2 2021, closing 88 positions and reducing 82 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $23.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Materials.

Against the trend, Pura Vida Investments opened a new position in AtaiBeckley Inc worth $23.2M.

  • Pura Vida Investments's largest Q2 2021 buy was AtaiBeckley Inc: 1,371,824 shares worth $23.2M.
  • Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q2 2021, an estimated $9.15M increase.
  • Pura Vida Investments's biggest Q2 2021 reduction was STAAR Surgical, cutting an estimated $14.6M.
  • Pura Vida Investments fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $23.9M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $3.21B portfolio in Q2 2021.
  • Pura Vida Investments opened 89 new positions and closed 88 in Q2 2021.
  • Pura Vida Investments's portfolio value fell 8.4% quarter-over-quarter to $3.21B.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.